menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

High-Tech Cardiovascular Risk Assessment

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    The means for assessing cardiovascular risk include several new high technology developments.  Dr. James Ehrlich, MD, a veteran in the development of advanced coronary risk assessment centers, educates us on the role of electron beam computed tomography (EBCT), endothelial function testing, and aspirin resistance testing in preventative cardiology.  Dr. Ehrlich also examines the research concerning new biomarkers of vascular disease, such C-reactive protein and urine thrombaxane B2.    Host Dr. Kaskel reviews with Dr Ehrlich the protocols for using these high tech devices prior to or in conjunction with ordering advanced imaging tests. 

    Brought to you by:

    NLA logo

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The means for assessing cardiovascular risk include several new high technology developments.  Dr. James Ehrlich, MD, a veteran in the development of advanced coronary risk assessment centers, educates us on the role of electron beam computed tomography (EBCT), endothelial function testing, and aspirin resistance testing in preventative cardiology.  Dr. Ehrlich also examines the research concerning new biomarkers of vascular disease, such C-reactive protein and urine thrombaxane B2.    Host Dr. Kaskel reviews with Dr Ehrlich the protocols for using these high tech devices prior to or in conjunction with ordering advanced imaging tests. 

    Brought to you by:

    NLA logo

     

Facebook Comments

Programs 9/23/21